http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003534375-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 2001-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2003-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2003534375-A
titleOfInvention Treatment of androgen deficiency in men with selective antiestrogens
abstract (57) [Summary]nMale menopause is characterized by a significant decrease in serum levels of bioavailable androgens. Administration of antiestrogens to men experiencing male menopause can treat relative androgen deficiency in men by stimulating the body's testosterone production.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015044867-A
priorityDate 2000-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4894373-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9965228-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6242953-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9926962-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416129693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534840
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419692051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448860624
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25010734

Total number of triples: 50.